College of Veterinary Medicine, Northeast Agricultural University, Harbin, China.
School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, China.
Front Immunol. 2023 Oct 6;14:1263586. doi: 10.3389/fimmu.2023.1263586. eCollection 2023.
Bacterium-like particles (BLPs) are hollow peptidoglycan particles obtained from food-grade inactivated by hot acid. With the advantage of easy preparation, high safety, great stability, high loading capacity, and high mucosal delivery efficiency, BLPs can load and display proteins on the surface with the help of protein anchor (PA), making BLPs a proper delivery system. Owning to these features, BLPs are widely used in the development of adjuvants, vaccine carriers, virus/antigens purification, and enzyme immobilization. This review has attempted to gather a full understanding of the technical composition, characteristics, applications. The mechanism by which BLPs induces superior adaptive immune responses is also discussed. Besides, this review tracked the latest developments in the field of BLPs, including -derived BLPs and novel anchors. Finally, the main limitations and proposed breakthrough points to further enhance the immunogenicity of BLPs vaccines were discussed, providing directions for future research. We hope that further developments in the field of antigen delivery of subunit vaccines or others will benefit from BLPs.
细菌样颗粒(BLPs)是从食品级经热酸灭活后获得的中空肽聚糖颗粒。由于其制备简单、安全性高、稳定性好、载药量高、黏膜传递效率高等优点,BLPs 可以在蛋白锚(PA)的帮助下在表面装载和展示蛋白质,使其成为一种合适的递送系统。由于这些特性,BLPs 广泛应用于佐剂、疫苗载体、病毒/抗原纯化和酶固定化的开发。本综述试图全面了解 BLPs 的技术组成、特性和应用。还讨论了 BLPs 诱导优越适应性免疫反应的机制。此外,本综述还跟踪了 BLPs 领域的最新发展,包括衍生 BLPs 和新型锚。最后,讨论了进一步提高 BLPs 疫苗免疫原性的主要限制和提出的突破点,为未来的研究提供了方向。我们希望,亚单位疫苗或其他抗原递药领域的进一步发展将受益于 BLPs。